Journal
Clinical Cancer Research
Publication Date
12-2-2024
Volume
30
Issue
23
First Page
5304
Last Page
5313
Document Type
Open Access Publication
DOI
10.1158/1078-0432.CCR-24-2113
Rights and Permissions
Neven P, Stahl N, Vidal M, Martín M, Kaufman PA, Harbeck N, Hunt KK, Carter S, Bidard FC, Fasching PA, Aftimos P, Wheatley D, Hamilton E, Aft R, Kulkarni S, Schmid P, Bhave M, Ismail-Khan R, Karacsonyi C, Estrem ST, Nguyen B, Ozbek U, Yuen E, Rodrik-Outmezguine V, Ciruelos E. A Preoperative Window-of-Opportunity Study of Oral SERD, Imlunestrant, in Newly Diagnosed ER-Positive, HER2-Negative Early Breast Cancer: Results from the EMBER-2 Study. Clin Cancer Res. 2024 Dec 2;30(23):5304-5313. doi: 10.1158/1078-0432.CCR-24-2113 This open access article is distributed under the Creative Commons AttributionNonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) license. ©2024 The Authors; Published by the American Association for Cancer Research
Recommended Citation
Neven, Patrick; Aft, Rebecca; and et al., "A preoperative window-of-opportunity study of oral SERD, imlunestrant, in newly diagnosed ER-positive, HER2-negative early breast cancer: Results from the EMBER-2 study." Clinical Cancer Research. 30, 23. 5304 - 5313. (2024).
https://digitalcommons.wustl.edu/oa_4/4492
Department
ICTS (Institute of Clinical and Translational Sciences)
Additional Links
Supplemental material is available for this article at publisher site.
